Prostatis Group’s iShares Core MSCI Total International Stock ETF IXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-41,889
Closed -$42.9K 171
2023
Q2
$42.9K Buy
+41,889
New +$2.62M 0.02% 188
2022
Q1
Sell
-7,412
Closed -$526K 92
2021
Q4
$526K Sell
7,412
-2,313
-24% -$166K 0.32% 48
2021
Q3
$690K Sell
9,725
-555
-5% -$40.5K 0.41% 50
2021
Q2
$754K Sell
10,280
-769
-7% -$56.3K 0.51% 46
2021
Q1
$777K Sell
11,049
-1,410
-11% -$98.9K 0.61% 36
2020
Q4
$837K Buy
+12,459
New +$783K 0.7% 32

Other funds holding IXUS

Prostatis Group's IXUS Position: Q3 2023 in Review

Prostatis Group sold out of iShares Core MSCI Total International Stock ETF (IXUS) in Q3 2023, closing a stake of 41,889 shares — an estimated $42.9K sold.

Prostatis Group first reported a position in IXUS in Q4 2020 and held it in 6 quarters. The position peaked at $837K in Q4 2020. 652 funds tracked by Wall St. Rank hold IXUS as of Q3 2023.

  • Prostatis Group reported no remaining iShares Core MSCI Total International Stock ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 41,889 iShares Core MSCI Total International Stock ETF shares in Q3 2023, an estimated $42.9K.
  • Prostatis Group first reported a position in iShares Core MSCI Total International Stock ETF in Q4 2020 and held it in 6 quarters.
  • Prostatis Group's iShares Core MSCI Total International Stock ETF position peaked at $837K in Q4 2020.
  • 652 funds tracked by Wall St. Rank held iShares Core MSCI Total International Stock ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.